# Genomic-Medicine-Analytics-Stack
An End-to-End, Reproducible Genomic Medicine Analytics Stack, Population Structure Control, Statistical Genetics, Cancer Mutational Signatures, Clonality, and AI-Assisted Variant Prioritisation.

An end-to-end, reproducible notebook workflow for population structure control, GWAS, PRS transferability audits, cancer mutational signatures and clonality, and governance-ready AI-assisted variant prioritisation.

**Author:** Mark I.R. Petalcorin  
Methods and resources, computational genomics, genomic medicine

## What this repository is
This repository contains a single, fully reproducible, end-to-end **genomic medicine analytics blueprint** implemented in a notebook. It mirrors real-world workflows across:

1. **Population genomics QC + structure**
2. **Statistical genetics (GWAS, fine mapping proxy, PRS + transferability audits)**
3. **Cancer genomics (TMB, mutational signatures via NMF, clonality proxy from VAF mixtures)**
4. **AI-assisted variant prioritisation with governance-ready evaluation (calibration, interpretability, group-wise auditing)**

All data are **simulated but biologically plausible**, generated deterministically from fixed random seeds, and all figures and tables are produced by running the notebook.

## Core artifact
- `Genomic_Medicine.ipynb`
  
  Runs end-to-end and generates all plots and summary tables.

## Repository structure 
```
├── Genomic_Medicine.ipynb
├── README.md
├── MODEL_CARD.md
├── DATASHEET.md
├── figures/
└── outputs/
    ├── tables/
    └── reports/
```
## How to run
	1.	Create and activate a Python environment (Python 3.10+ recommended).
	2.	Install dependencies:
```
  pip install numpy pandas scikit-learn matplotlib scipy
```
  3.   Run Genomic_Medicine.ipynb top-to-bottom.

##  What you get when you run it
	•	Cohort QC distributions, missingness checks, MAF spectrum
	•	PCA + t-SNE structure plots, ancestry differentiation heatmap
	•	GWAS Manhattan + QQ plots and λGC, top hits table
	•	Approximate fine mapping credible set (proxy)
	•	PRS evaluation with ROC, PR, calibration, and ancestry-stratified metrics
	•	Tumour mutational signatures (96-channel) using NMF, exposure heatmap, TMB distribution
	•	Clonality proxy: VAF mixture modelling for example tumours
	•	Variant prioritisation ML: AUROC, PR-AUC, calibration, permutation importance, partial dependence, group-wise auditing

## Governance posture
This notebook explicitly demonstrates that high AUC alone is not sufficient for deployment. It includes:
	•	Calibration checks (Brier score + reliability curves)
	•	Group-wise robustness audits (ancestry strata performance)
	•	Interpretability (permutation importance + partial dependence)
	•	Report-ready summary tables suitable for programme leadership

## Citation
Petalcorin, M.I.R. (2026). An End-to-End, Reproducible Genomic Medicine Analytics Stack, Population Structure Control, Statistical Genetics, Cancer Mutational Signatures, Clonality, and Trustworthy AI-Assisted Variant Prioritisation. GitHub. https://github.com/mpetalcorin/Genomic-Medicine-Analytics-Stack

## References 
Alexandrov, L.B., Nik-Zainal, S., Wedge, D.C., et al. (2013). Signatures of mutational processes in human cancer. Nature, 500, 415–421. https://doi.org/10.1038/nature12477 

Alexandrov, L.B., Kim, J., Haradhvala, N.J., et al. (2020). The repertoire of mutational signatures in human cancer. Nature, 578, 94–101. https://doi.org/10.1038/s41586-020-1943-3 

Popejoy, A.B., Fullerton, S.M. (2016). Genomics is failing on diversity. Nature, 538, 161–164. https://doi.org/10.1038/538161a 

Price, A.L., Patterson, N.J., Plenge, R.M., et al. (2006). Principal components analysis corrects for stratification in genome-wide association studies. Nature Genetics, 38, 904–909. https://doi.org/10.1038/ng1847

Richards, S., Aziz, N., Bale, S., et al. (2015). Standards and guidelines for the interpretation of sequence variants. Genetics in Medicine, 17, 405–424. https://doi.org/10.1038/gim.2015.30 

Sirugo, G., Williams, S.M., Tishkoff, S.A. (2019). The missing diversity in human genetic studies. Cell, 177, 26–31. https://doi.org/10.1016/j.cell.2019.02.048 
